Brief: Index Pharmaceuticals Q4 Oper Loss Widens To SEK 58.2 Mln
Feb 23 (Reuters) - InDex Pharmaceuticals Holding AB
INDEX.ST :
* Q4 NET SALES AMOUNTED TO SEK 0.0 (0.0) MILLION
* Q4 OPERATING LOSS AMOUNTED TO SEK -58.2 (-22.7) MILLION
* RESULTS OF PK STUDY TO BE REPORTED IN Q1
Source text for Eikon: ID:nWkr9vtnfQ
Further company coverage: INDEX.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen